Bliss GVS Pharma Limited has informed the Exchange regarding Board meeting held on September 30, 2025.

Promoter Family Board EntryManagement Changes View source PDF Explain this filing

BLISSGVS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.7%Reaction day

₹151.20

prior close

₹152.79

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.4%+0.3% vs market

Pharmaceuticals peers, median of 152sector+1.0%+0.6% vs sector

On the reaction day the stock moved 0.3 pts more than Nifty Microcap 250 and 0.6 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.2

10m

+0.5

15m

+0.1

30m

-0.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.7+1.4+0.3+1.0+0.6

Next day

+0.1+2.7-2.6+1.4-1.2

+1.5+2.4-0.9+1.3+0.2

+1.0+2.2-1.2+0.7+0.3

+0.5+1.9-1.4+0.3+0.3

+4.4+2.1+2.3+0.6+3.8

+2.5+2.3+0.3+0.9+1.6

15d

+0.7+3.4-2.7+0.6+0.0

+2.8+5.0-2.3+1.9+0.9

+2.7+0.8+1.9-2.7+5.5

+7.1-1.3+8.4-4.2+11.4

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 152Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Bliss GVS Pharma's board, at its meeting on September 30, 2025, approved the appointment of Mr. Narsimha Shibroor Kamath as Chief Executive Officer with immediate effect. Mr. Kamath is the founder and Promoter of the company, who originally acquired Bliss Chemicals & Pharmaceuticals and built the business into one exporting to over 60 countries. The appointment is for an unspecified term, with the board meeting running from 4:15 PM to 5:00 PM. His profile and relationship disclosures show he is the father-in-law of the Managing Director (Mr. Gagan Sharma) and father of two Whole-Time Directors (Dr. Vibha Sharma and Mrs. Shruti Rao).

Likely market impact

Leadership is now fully in promoter-family hands, with the founder as CEO, his son-in-law as MD, and his two daughters as Whole-Time Directors. This sharpens strategic direction under the original promoter but concentrates decision-making and raises corporate governance concerns for minority shareholders.